SGLT2 Rx Tool

This tool was created to help providers understand the benefits and risks of SGLT2 inhibitors for patients with and without diabetes.

General Benefits of SGLT2 Inhibitors

Hemoglobin A1C (0.5%)
Body weight (5 lbs)
Proteinuria (by 50%)
Systolic blood pressure (5 mmHg)
Do not cause hypoglycemia

Patient-Specific Benefits of SGLT2 Inhibitors

Please enter all required patient information.

Made by Dr. Michael Fralick, Andy Zhao, Michelle Gyenes, and Jason Moggridge.
Funded by BioTalent Canada and Sinai Health Department of Medicine Research Fund.

Provide Feedback